Excellent outcome of haploidentical hematopoietic stem cell transplantation in children and adolescents with acquired severe aplastic anemia

Biology of Blood and Marrow Transplantation

Volumn 19, Issue 5, 2013, Pages 754-759

  Im, Ho Joon ^a   Koh, Kyung Nam ^a   Choi, Eun Seok ^a   Jang, Seongsoo ^a   Kwon, Seog Woon ^a   Park, Chan Jeoung ^a   Chi, Hyun Sook ^a   Seo, Jong Jin ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Children and adolescents; Haploidentical stem cell transplantation; Severe aplastic anemia; T cell depletion

Indexed keywords

CD3 ANTIGEN; CYCLOPHOSPHAMIDE; FLUDARABINE; FOSCARNET; GRANULOCYTE COLONY STIMULATING FACTOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; THYMOCYTE ANTIBODY; VALGANCICLOVIR;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; APLASTIC ANEMIA; ARTICLE; CHILD; CLINICAL ARTICLE; FEMALE; FOLLOW UP; GRAFT REJECTION; HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MALE; NEUTROPHIL; PERIPHERAL BLOOD STEM CELL; PRESCHOOL CHILD; SCHOOL CHILD; SEVERE APLASTIC ANEMIA; T CELL DEPLETION; TREATMENT DURATION; TREATMENT OUTCOME;

ADOLESCENT; ANEMIA, APLASTIC; CHILD; CHILD, PRESCHOOL; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HAPLOIDY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; T-LYMPHOCYTES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84876326981     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2013.01.023     Document Type: Article

References (33)

1. Guinan E.C. Acquired aplastic anemia in childhood. Hematol Oncol Clin North Am 2009, 23:171-191.
2. Young N.S., Calado R.T., Scheinberg P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood 2006, 108:2509-2519.
3. Scheinberg P., Young N.S. How I treat acquired aplastic anemia. Blood 2012, 120:1185-1196.
4. Keever C.A., Small T.N., Flomenberg N., et al. Immune reconstitution following bone marrow transplantation: comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts. Blood 1989, 73:1340-1350.
5. Handgretinger R., Klingebiel T., Lang P., et al. Megadose transplantation of highly purified haploidentical stem cells: current results and future prospects. Pediatr Ttransplant 2003, 7(suppl 3):51-55.
6. Kremens B., Basu O., Grosse-Wilde H., et al. Transplantation of CD34-enriched peripheral stem cells from an HLA-haplotype mismatched donor to a patient with severe aplastic anemia. Bone Marrow Transplant 2001, 27:111-113.
7. Woodard P., Cunningham J.M., Benaim E., et al. Effective donor lymphohematopoietic reconstitution after haploidentical CD34+-selected hematopoietic stem cell transplantation in children with refractory severe aplastic anemia. Bone Marrow Transplant 2004, 33:411-418.
8. Lacerda J.F., Martins C., Carmo J.A., et al. Haploidentical stem cell transplantation with purified CD34+ cells after a chemotherapy-alone conditioning regimen in heavily transfused severe aplastic anemia. Biol Blood Marrow Transplant 2005, 11:399-400.
9. Bethge W.A., Faul C., Bornhauser M., et al. Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update. Blood Cells Mol Dis 2008, 40:13-19.
10. Handgretinger R., Chen X., Pfeiffer M., et al. Feasibility and outcome of reduced-intensity conditioning in haploidentical transplantation. Ann N Y Acad Sci 2007, 1106:279-289.
11. Lang P., Schumm M., Greil J., et al. A comparison between three graft manipulation methods for haploidentical stem cell transplantation in pediatric patients: preliminary results of a pilot study. Klin Padiatr 2005, 217:334-338.
12. Koh K.N., Im H.J., Kim B.E., et al. Haploidentical haematopoietic stem cell transplantation using CD3 or CD3/CD19 depletion and conditioning with fludarabine, cyclophosphamide and antithymocyte globulin for acquired severe aplastic anaemia. Br J Haematol 2012, 157:139-142.
13. Filipovich A.H., Weisdorf D., Pavletic S., et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease. I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005, 11:945-956.
14. Przepiorka D., Weisdorf D., Martin P., et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995, 15:825-828.
15. Boulad F., Gillio A., Small T.N., et al. Stem cell transplantation for the treatment of Fanconi anaemia using a fludarabine-based cytoreductive regimen and T-cell-depleted related HLA-mismatched peripheral blood stem cell grafts. Br J Haematol 2000, 111:1153-1157.
16. Wagner J.E., Eapen M., MacMillan M.L., et al. Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia. Blood 2007, 109:2256-2262.
17. Chaudhury S., Auerbach A.D., Kernan N.A., et al. Fludarabine-based cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi anaemia. Br J Haematol 2008, 140:644-655.
18. Yagasaki H., Takahashi Y., Hama A., et al. Comparison of matched-sibling donor BMT and unrelated donor BMT in children and adolescent with acquired severe aplastic anemia. Bone Marrow Transplant 2010, 45:1508-1513.
19. Bacigalupo A., Socie G., Lanino E., et al. Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working Party. Haematologica 2010, 95:976-982.
20. Kang H.J., Shin H.Y., Park J.E., et al. Successful engraftment with fludarabine, cyclophosphamide, and thymoglobulin conditioning regimen in unrelated transplantation for severe aplastic anemia: a phase II prospective multicenter study. Biol Blood Marrow Transplant 2010, 16:1582-1588.
21. Samarasinghe S., Steward C., Hiwarkar P., et al. Excellent outcome of matched unrelated donor transplantation in paediatric aplastic anaemia following failure with immunosuppressive therapy: a United Kingdom multicentre retrospective experience. Br J Haematol 2012, 157:339-346.
22. Yoshimi A., Kojima S., Taniguchi S., et al. Unrelated cord blood transplantation for severe aplastic anemia. Biol Blood Marrow Transplant 2008, 14:1057-1063.
23. Peffault de Latour R., Purtill D., Ruggeri A., et al. Influence of nucleated cell dose on overall survival of unrelated cord blood transplantation for patients with severe acquired aplastic anemia: a study by eurocord and the aplastic anemia working party of the European group for blood and marrow transplantation. Biol Blood Marrow Transplant 2011, 17:78-85.
24. Liu H.L., Sun Z.M., Geng L.Q., et al. Unrelated cord blood transplantation for newly diagnosed patients with severe acquired aplastic anemia using a reduced-intensity conditioning: high graft rejection, but good survival. Bone Marrow Transplant 2012, 47:1186-1190.
25. Xu L.P., Liu K.Y., Liu D.H., et al. A novel protocol for haploidentical hematopoietic SCT without in vitro T-cell depletion in the treatment of severe acquired aplastic anemia. Bone Marrow Transplant 2012, 47:1507-1512.
26. Lang P., Greil J., Bader P., et al. Long-term outcome after haploidentical stem cell transplantation in children. Blood Cells Mol Dis 2004, 33:281-287.
27. Klingebiel T., Cornish J., Labopin M., et al. Results and factors influencing outcome after fully haploidentical hematopoietic stem cell transplantation in children with very high-risk acute lymphoblastic leukemia: impact of center size: an analysis on behalf of the Acute Leukemia and Pediatric Disease Working Parties of the European Blood and Marrow Transplant group. Blood 2010, 115:3437-3446.
28. Champlin R.E., Horowitz M.M., van Bekkum D.W., et al. Graft failure following bone marrow transplantation for severe aplastic anemia: risk factors and treatment results. Blood 1989, 73:606-613.
29. Woodard P., Tong X., Richardson S., et al. Etiology and outcome of graft failure in pediatric hematopoietic stem cell transplant recipients. J Pediatr Hematol Oncol 2003, 25:955-959.
30. Kato S., Yabe H., Yasui M., et al. Allogeneic hematopoietic transplantation of CD34+ selected cells from an HLA haplo-identical related donor. A long-term follow-up of 135 patients and a comparison of stem cell source between the bone marrow and the peripheral blood. Bone Marrow Transplant 2000, 26:1281-1290.
31. Deeg H.J., Amylon I.D., Harris R.E., et al. Marrow transplants from unrelated donors for patients with aplastic anemia: minimum effective dose of total body irradiation. Biol Blood Marrow Transplant 2001, 7:208-215.
32. Larocca A., Piaggio G., Podesta M., et al. Boost of CD34+-selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantation. Haematologica 2006, 91:935-940.
33. Müller S., Schulz A., Reiss U., et al. Definition of a critical T cell threshold for prevention of GVHD after HLA non-identical PBPC transplantation in children. Bone Marrow Transplant 1999, 24:575-581.